Fab and Fc contribute to maximal protection against SARS-CoV-2 following NVX-CoV2373 subunit vaccine with Matrix-M vaccination

被引:81
作者
Gorman, Matthew J. [1 ]
Patel, Nita [2 ]
Guebre-Xabier, Mimi [2 ]
Zhu, Alex L. [1 ,3 ]
Atyeo, Caroline [1 ]
Pullen, Krista M. [4 ]
Loos, Carolin [1 ,4 ]
Goez-Gazi, Yenny [5 ]
Carrion, Ricardo, Jr. [5 ]
Tian, Jing-Hui [2 ]
Yuan, Dansu [1 ]
Bowman, Kathryn A. [1 ]
Zhou, Bin [2 ]
Maciejewski, Sonia [2 ]
McGrath, Marisa E. [6 ]
Logue, James [6 ]
Frieman, Matthew B. [6 ]
Montefiori, David [7 ]
Mann, Colin [8 ]
Schendel, Sharon [8 ]
Amanat, Fatima [9 ]
Krammer, Florian [9 ,10 ]
Saphire, Erica Ollmann [8 ]
Lauffenburger, Douglas A. [4 ]
Greene, Ann M. [2 ]
Portnoff, Alyse D. [2 ]
Massare, Michael J. [2 ]
Ellingsworth, Larry [2 ]
Glenn, Gregory [2 ]
Smith, Gale [2 ]
Alter, Galit [1 ]
机构
[1] Ragon Inst MGH MIT & Harvard, Cambridge, MA 02139 USA
[2] Novavax Inc, 21 Firstfield Rd, Gaithersburg, MD 20878 USA
[3] Univ Duisburg Essen, Virol & Immunol Program, Essen, Germany
[4] MIT, Dept Biol Engn, Cambridge, MA 02139 USA
[5] Texas Biomed Res Inst, 8715 West Mil Dr, San Antonio, TX 78227 USA
[6] Univ Maryland, Sch Med, 685 West Baltimore St, Baltimore, MD 21201 USA
[7] Duke Univ, Dept Surg, Med Ctr, Durham, NC 27710 USA
[8] La Jolla Inst Immunol, La Jolla, CA 92037 USA
[9] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY USA
[10] Icahn Sch Med Mt Sinai, Dept Pathol, New York, NY USA
基金
美国国家科学基金会;
关键词
RECEPTOR-BINDING DOMAIN; ANTIBODIES; SPIKE; CELLS;
D O I
10.1016/j.xcrm.2021.100405
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Recently approved vaccines have shown remarkable efficacy in limiting SARS-CoV-2-associated disease. However, with the variety of vaccines, immunization strategies, and waning antibody titers, defining the correlates of immunity across a spectrum of antibody titers is urgently required. Thus, we profiled the humoral immune response in a cohort of non-human primates immunized with a recombinant SARS-CoV-2 spike glycoprotein (NVX-CoV2373) at two doses, administered as a single-or two-dose regimen. Both antigen dose and boosting significantly altered neutralization titers and Fc-effector profiles, driving unique vaccine-induced antibody fingerprints. Combined differences in antibody effector functions and neutralization were associated with distinct levels of protection in the upper and lower respiratory tract. Moreover, NVX-CoV2373 elicited antibodies that functionally targeted emerging SARS-CoV-2 variants. Collectively, the data presented here suggest that a single dose may prevent disease via combined Fc/Fab functions but that two doses may be essential to block further transmission of SARS-CoV-2 and emerging variants.
引用
收藏
页数:23
相关论文
共 84 条
[1]   Immunogenicity of Ad26.COV2.S vaccine against SARS-CoV-2 variants in humans [J].
Alter, Galit ;
Yu, Jingyou ;
Liu, Jinyan ;
Chandrashekar, Abishek ;
Borducchi, Erica N. ;
Tostanoski, Lisa H. ;
McMahan, Katherine ;
Jacob-Dolan, Catherine ;
Martinez, David R. ;
Chang, Aiquan ;
Anioke, Tochi ;
Lifton, Michelle ;
Nkolola, Joseph ;
Stephenson, Kathryn E. ;
Atyeo, Caroline ;
Shin, Sally ;
Fields, Paul ;
Kaplan, Ian ;
Robins, Harlan ;
Amanat, Fatima ;
Krammer, Florian ;
Baric, Ralph S. ;
Le Gars, Mathieu ;
Sadoff, Jerald ;
de Groot, Anne Marit ;
Heerwegh, Dirk ;
Struyf, Frank ;
Douoguih, Macaya ;
van Hoof, Johan ;
Schuitemaker, Hanneke ;
Barouch, Dan H. .
NATURE, 2021, 596 (7871) :268-+
[2]   Delayed Second Dose versus Standard Regimen for Covid-19 Vaccination [J].
不详 .
NEW ENGLAND JOURNAL OF MEDICINE, 2021, 384 (09) :E281-E283
[3]  
[Anonymous], 2021, NATURE, V589, P169, DOI 10.1038/d41586-021-00045-8
[4]   Distinct Early Serological Signatures Track with SARS-CoV-2 Survival [J].
Atyeo, Caroline ;
Fischinger, Stephanie ;
Zohar, Tomer ;
Slein, Matthew D. ;
Burke, John ;
Loos, Carolin ;
McCulloch, Denise J. ;
Newman, Kira L. ;
Wolf, Caitlin ;
Yu, Jingyou ;
Shuey, Kiel ;
Feldman, Jared ;
Hauser, Blake Marie ;
Caradonna, Tim ;
Schmidt, Aaron G. ;
Suscovich, Todd J. ;
Linde, Caitlyn ;
Cai, Yongfei ;
Barouch, Dan ;
Ryan, Edward T. ;
Charles, Richelle C. ;
Lauffenburger, Douglas ;
Chu, Helen ;
Alter, Galit .
IMMUNITY, 2020, 53 (03) :524-+
[5]   Phase 1/2 trial of SARS-CoV-2 vaccine ChAdOx1 nCoV-19 with a booster dose induces multifunctional antibody responses [J].
Barrett, Jordan R. ;
Belij-Rammerstorfer, Sandra ;
Dold, Christina ;
Ewer, Katie J. ;
Folegatti, Pedro M. ;
Gilbride, Ciaran ;
Halkerston, Rachel ;
Hill, Jennifer ;
Jenkin, Daniel ;
Stockdale, Lisa ;
Verheul, Marije K. ;
Aley, Parvinder K. ;
Angus, Brian ;
Bellamy, Duncan ;
Berrie, Eleanor ;
Bibi, Sagida ;
Bittaye, Mustapha ;
Carroll, Miles W. ;
Cavell, Breeze ;
Clutterbuck, Elizabeth A. ;
Edwards, Nick ;
Flaxman, Amy ;
Fuskova, Michelle ;
Gorringe, Andrew ;
Hallis, Bassam ;
Kerridge, Simon ;
Lawrie, Alison M. ;
Linder, Aline ;
Liu, Xinxue ;
Madhavan, Meera ;
Makinson, Rebecca ;
Mellors, Jack ;
Minassian, Angela ;
Moore, Maria ;
Mujadidi, Yama ;
Plested, Emma ;
Poulton, Ian ;
Ramasamy, Maheshi N. ;
Robinson, Hannah ;
Rollier, Christine S. ;
Song, Rinn ;
Snape, Matthew D. ;
Tarrant, Richard ;
Taylor, Stephen ;
Thomas, Kelly M. ;
Voysey, Merryn ;
Watson, Marion E. E. ;
Wright, Daniel ;
Douglas, Alexander D. ;
Green, Catherine M. .
NATURE MEDICINE, 2021, 27 (02) :279-+
[6]  
Bernal JL., 2021, EARLY EFFECTIVENESS, p2021030121252652, DOI [10.1101/2021.03.01.21252652, DOI 10.1101/2021.03.01.21252652]
[7]   The role of IgG Fc receptors in antibody-dependent enhancement [J].
Bournazos, Stylianos ;
Gupta, Aaron ;
Ravetch, Jeffrey, V .
NATURE REVIEWS IMMUNOLOGY, 2020, 20 (10) :633-643
[8]   Diversification of IgG effector functions [J].
Bournazos, Stylianos ;
Ravetch, Jeffrey V. .
INTERNATIONAL IMMUNOLOGY, 2017, 29 (07) :303-310
[9]   Fcγ receptor pathways during active and passive immunization [J].
Bournazos, Stylianos ;
Ravetch, Jeffrey V. .
IMMUNOLOGICAL REVIEWS, 2015, 268 (01) :88-103
[10]   Multiplexed Fc array for evaluation of antigen-specific antibody effector profiles [J].
Brown, Eric P. ;
Dowell, Karen G. ;
Boesch, Austin W. ;
Normandin, Erica ;
Mahan, Alison E. ;
Chu, Thach ;
Barouch, Dan H. ;
Bailey-Kellogg, Chris ;
Alter, Galit ;
Ackerman, Margaret E. .
JOURNAL OF IMMUNOLOGICAL METHODS, 2017, 443 :33-44